Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial network morphology and function in the caudate after intrastriatal injection of amyloid peptides

Current Alzheimer Research

Volumn 4, Issue 3, 2007, Pages 305-313

  Leo, Giuseppina ^a,b   Genedani, Susanna ^a,b   Filaferro, Monica ^a,b   Carone, Chiara ^a   Andreoli, Norma ^a   Astancolle, Serenella ^a   Davalli, Pierpaolo ^a   Fuxe, Kjell ^c   Agnati, Luigi F ^a,b,d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Section of Physiology   (Italy)

Author keywords

amyloid; Clusterin; GFAP; Homocysteine; Neuroglial network; Pain; Rat; TH

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PROTEIN; CLUSTERIN; METHIONINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BASAL GANGLION; BETA SHEET; CAUDATE NUCLEUS; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; GLIA CELL; HYPERHOMOCYSTEINEMIA; IMMUNOREACTIVITY; MALE; NEUROFILAMENT; NEUROTRANSMISSION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; CAUDATE NUCLEUS; CLUSTERIN; DRUG INTERACTIONS; FOOD, FORMULATED; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; MODELS, BIOLOGICAL; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; THIAZOLES;

EID: 34347404843     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720507781077223     Document Type: Article

References (44)

1. Selkoe DJ. Aging, amyloid and Alzheimer's disease: A perspective in honor of Carl Cotman. Neurochem Res 28: 1705-1713 (2003).
2. Chang KA and Suh YH. Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the β-amyloid precursor protein in Alzheimer's disease. J Pharmacol Sci 97: 461-471 (2005).
3. Esteban JA. Living with the enemy: a physiological role for the beta-amyloid peptide. Trends Neurosci 27: 1-3 (2004).
4. Fezoui Y and Teplow DB. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. J Biol Chem 277: 36948-36954 (2002).
5. Kallberg Y, Gustafsson M, Persson B, Thyberg J and Johansson J. Prediction of amyloid fibril-forming proteins. J Biol Chem 276: 12945-12950 (2001).
6. Roher AE, Baudry J, Chaney MO, Kuo YM, Stine WB and Emmerling MR. Oligomerizaiton and fibril assembly of the amyloid-beta protein. Biochim Biophys Acta 1502: 31-43 (2000).
7. DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM and Holtzman DM. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41: 193-202 (2004).
8. Ho PI, Collins SC, Dhitavat S, Ortiz D, Ashline D, Rogers E and Shea TB. Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem 78: 249-53 (2001).
9. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW and Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl J Med 346: 476-483 (2002).
10. Agnati LF, Genedani S, Rasio G, Galantucci M, Saltini S, Filaferro M, Franco R, Mora F, Ferrè S and Fuxe K. Studies on homocysteine plasma levels in Alzheimer's patients. Relevance for neurodegeneration. J Neural Transm 112:163-169 (2005).
11. Genedani S, Rasio G, Cortelli P, Antonelli F, Guidolin D, Galantucci M, Fuxe K and Agnati LF. Studies on homocysteine and dehydroepiandrsterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients. Neurotox Res 6:327-332 (2004).
12. Agnati LF, Genedani S, Leo G, Forni A, Woods AS, Filaferro M and Fuxe K. Aβ peptides as one of the crucial Volume Transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease. J Neural Transm (in press).
13. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C and Scott JM. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion. Clin Chem 50: 3-32 (2004).
14. Stephan A, Laroche S and Davis S. Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21: 5703-5714 (2001).
15. Hirayama A, Horikoshi Y, Maeda M, Ito M and Takashima S. Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome. Brain Dev 25: 180-185 (2003).
16. Agnati LF and Fuxe K. Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine. Prog Brain Res 125: 3-19 (2000).
17. Chudler EH and Dong WK. The role of basal ganglia in nociception and pain. Pain 60: 3-38 (1995).
18. Fu W, Dudman NPB, Perry MA, Young K and Wang XL. Interrelations between plasma homocysteine and intracellular Sadenosylhomocysteine. Biochem Biophys Res Comm 271: 47-53 (2000).
19. Pfeiffer CM, Huff DL and Gunter EW. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45: 290-292 (1999).
20. Agnati LF and Fuxe K. In: "Quantitative Neuroanatomy in Transmitter Research". (Eds: Agnati LF and Fuxe K), MacMillan Press, London, p. 91-112 (1985).
21. Agnati LF, Fuxe K, Torvinen M, Genedani S, Watson S, Franco R, Leo G, and Guidolin D. New methods to evaluate co-localization of fluorophores in immunocytochemical prepartions as exemplified by a study on A2A and D2 receptors in CHO. J Histochem Cytochem 53: 941-953 (2005).
22. Hargreaves K, Dubner R, Brown F, Flores C and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88 (1998).
23. Conover WJ. Practical Nonparametric Statistics. John Wiley, New York (1971).
24. Ungvari Z, Pacher P, Rischak K, Szollar L and Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 19:1899 -1904 (1999).
25. Makin OS, Atkins E, Sikorski P, Johansson J and Serpell LC. Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci USA 102: 315-320 (2005).
26. Kirkitadze MD, Condron MM and Teplow DB. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol 312: 1103-1119 (2001).
27. 2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells. Cell Death Differ 12: 101-104 (2005).
28. DeMattos RB, O'Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, Paul SM, Aronow BJ and Holtzman DM. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 99: 10843-10848 (2002).
29. Zlokovic BV, Martel CL, Matsubara E, McComb JG, Zheng G, McCluskey RT, Frangione B and Ghiso J. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci USA 93: 4229-4234 (1996).
30. Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28: 202-208 (2005)
31. Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA and Martins RN. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev 43: 1-16 (2003).
32. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR and Stamler JS. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-daspartate receptor. Proc Natl Acad Sci USA 94: 5923-5928 (1997).
33. Mattson MP and Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26: 137-146 (2003).
34. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB and Smith MA. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767 (2001).
35. Zlokovic BV. Clearing amyloid through the blood-brain barrier. J Neurochem 89: 807-811 (2004).
36. Schliebs R. Basal forebrain cholinergic dysfunction in Alzheimer's disease - Interrelationships with β-amyloid, inflammation and neurotrphin signaling. Neurochem Res 30: 895-908 (2005).
37. Klingner M, Apelt J, Kumar A, Sorger D, Sabri O, Steinbach J, Scheunemann M and Schliebs R. Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology. Int J Dev Neurosci 21: 357-369 (2003).
38. Nicholson C and Sykova E. Extracellular space structure revealed by diffusion analysis. Trends Neurosci 21: 207-215 (1998).
39. Roitbak T and Syková E. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 28: 40-48 (1999).
40. Takeda R, Ikeda T, Tsuda F, Abe H, Hashiguchi H, Ishida Y and Nishimori T. Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation. Neurosci Res 52: 31-36 (2005).
41. Rosland JH, Hunskaar S, Broch OJ and Hole K. Acute and long term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in tests of nociception in mice. Pharmacol Toxicol 70: 31-37 (1992).
42. Altier N and Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65: 2269-2287 (1999).
43. Braz JM, Nassar MA, Wood JN and Basbaum AI. Parallel "pain" pathways arise from subpopulations of primary afferent nociceptor. Neuron 47: 787-793 (2005).
44. Lee HG, Castellani RJ, Zhu X, Perry G and Smith MA. Amyloid-β in Alzheimer's disease: the horse or the cart? Pathogenetic or protective? Int J Exp Path 86: 133-138 (2005).